# FUROSCIX

NDC: 71767-111
Generic name: furosemide
Labeler / Manufacturer: scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20260727

FDA application: NDA209988

## Active ingredients

- FUROSEMIDE: 80 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71767-111"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71767-111
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eac958dd-8d43-e44e-e053-2995a90a4d5e